Protective effect of intra-peritoneal epinephrine on postoperative renal function after cisplatin-based intra-peritoneal intra-operative chemotherapy.

Date publication

juin 2011

Journal

European journal of obstetrics, gynecology, and reproductive biology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr CHALOPIN Jean-Marc , Pr PIVOT Xavier , Dr ROYER Bernard , Pr HEYD Bruno

Tous les auteurs :
Pili-Floury S, Royer B, Bartholin F, Crumiere N, Combe M, Chalopin JM, Pivot X, Heyd B, Chauffert B, Samain E

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/21306815

Résumé

Intra-operative cisplatin-based intra-peritoneal chemotherapy (IPC) may alter renal function in patients with advanced ovarian cancer. The aim of this study was to describe postoperative alteration of renal function after cisplatin-based IPC and to identify risk factors for moderate to severe acute renal failure.

Mots clés

Acute Kidney Injury, chemically induced, Adult, Aged, Antineoplastic Agents, administration & dosage, Cisplatin, administration & dosage, Epinephrine, administration & dosage, Female, Humans, Infusions, Parenteral, Kidney, drug effects, Middle Aged, Ovarian Neoplasms, drug therapy, Prospective Studies, Vasoconstrictor Agents, administration & dosage

Référence

Eur. J. Obstet. Gynecol. Reprod. Biol.. 2011 Jun;156(2):199-203